Crossmark

Selective inhibition of peptidyl-arginine deiminase (PAD): can it control multiple inflammatory disorders as a promising therapeutic strategy?

Published Online: 2023-02-17

Published Print: 2023-04

Authors

Padhy, Dibya Sundar

Palit, Partha

Ikbal, Abu Md Ashif

Das, Nirupam

Roy, Dilip Kumar

Banerjee, Sugato https://orcid.org/0000-0002-1540-8223
License Information

Text and Data Mining valid from 2023-02-17

Version of Record valid from 2023-02-17
More Information

Article History

Received: 31 October 2022

Accepted: 19 January 2023

First Online: 17 February 2023

Declarations

:

: The authors have no conflict of interest.

Document is current